Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
66.7M
-
Shares change
-
-2.23M
-
Total reported value, excl. options
-
$474M
-
Value change
-
-$7.6M
-
Put/Call ratio
-
1.41
-
Number of buys
-
62
-
Number of sells
-
-69
-
Price
-
$7.12
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2020
165 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q2 2020.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.7M shares
of 117M outstanding shares and own 57.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.19M shares), BlackRock Inc. (5.82M shares), Bellevue Group AG (5.03M shares), DIMENSIONAL FUND ADVISORS LP (3.77M shares), CREDIT SUISSE AG/ (3.75M shares), EAGLE ASSET MANAGEMENT INC (2.89M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2.88M shares), BLAIR WILLIAM & CO/IL (2.53M shares), CARILLON TOWER ADVISERS, INC. (2.25M shares), and Bank of New York Mellon Corp (1.9M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.